Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 8 upcoming openings for the January – June 2018 co-op period.  We will be accepting applications starting in September 2017 via NUcareers.


CaNCURE Co-op Showcase

The CaNCURE Team would like to send out a congratulations to the 7 trainees who completed their CaNCURE co-op this June! We were so proud to see all your accomplishments at our third annual CaNCURE Nanomedicine Day and to learn that for many of you, this co-op was a career-defining experience!

 

 


 

Upcoming Events

Check back soon for new events


Mentor Spotlight


Jin-Rong Zhou, Ph.D.

Associate Professor of Surgery, HMS

Our lab studies the role of dietary/nutritional and natural bioactive compounds in the prevention and treatment of cancer. Students will compare oral and systemic administration of purified nanoparticle formulations of black tea components for their ability to inhibit prostate cancer progression to androgen-independence.


William S Hancock, Ph.D.

Professor of Chemistry, NEU

Our lab is focused on advanced protein characterization methods for the study of cancer mechanisms and discovery of potential therapeutic agents. Students will use a nanoLC/MS coupled to a LTQ-Orbitrap to identify glycoprotein biomarkers and protein therapeutics.


Trainee Spotlight


Patrick Sheedy

Justin Margolin

Health Science, '19

Evaluation of deep learning approaches in an integrated PET/MRI scanner to generate pelvis attenuation maps and characterize prostate cancer

Evan Mun

Biochemistry, '20

Discovering the Genetic Mechanism of Enhanced Metastatic Colonization in SMAD4 Mutant Tumors


Going on in the lab right now...